Authors:
Miller, MC
O'Dowd, GJ
Partin, AW
Veltri, RW
Citation: Mc. Miller et al., Contemporary use of complexed PSA and calculated percent free PSA for early detection of prostate cancer: Impact of changing disease demographics, UROLOGY, 57(6), 2001, pp. 1105-1111
Citation: Rw. Veltri et al., Standardization, analytical validation, and quality control of intermediate endpoint biomarkers, UROLOGY, 57(4A), 2001, pp. 164-170
Citation: Ay. Ng et al., Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell lines, ANAL QUAN C, 22(1), 2000, pp. 45-54
Authors:
Marks, LS
Partin, AW
Epstein, JI
Tyler, VE
Simon, I
Macairan, ML
Chan, TL
Dorey, FJ
Garris, JB
Veltri, RW
Santos, PBC
Stonebrook, KA
deKernion, JB
Citation: Ls. Marks et al., Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia, J UROL, 163(5), 2000, pp. 1451-1456
Authors:
An, G
Ng, AY
Meka, CSR
Luo, GZ
Bright, SP
Cazares, L
Wright, GL
Veltri, RW
Citation: G. An et al., Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers, CANCER RES, 60(24), 2000, pp. 7014-7020
Citation: Rw. Veltri, Serum PSA - What are the clinical indications for using serum prostate specific antigen (PSA) biomarker?, LAB MED, 31(5), 2000, pp. 253-254
Citation: Rw. Veltri, Molecular staging of prostate cancer: Dream or reality? The de la Taille/Olsson/Katz article reviewed, ONCOLOGY-NY, 13(2), 1999, pp. 205
Citation: G. An et al., Human prostate-specific transglutaminase gene: Promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer, UROLOGY, 54(6), 1999, pp. 1105-1111
Authors:
Potter, SR
Miller, MC
Mangold, LA
Jones, KA
Epstein, JI
Veltri, RW
Partin, AW
Citation: Sr. Potter et al., Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy, UROLOGY, 54(5), 1999, pp. 791-795
Citation: Rw. Veltri et Mc. Miller, Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: Critical analysis of two different test populations, UROLOGY, 53(4), 1999, pp. 736-745
Authors:
Veltri, RW
Miller, MC
Zhao, G
Ng, A
Marley, GM
Wright, GL
Vessella, RL
Ralph, D
Citation: Rw. Veltri et al., Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer, UROLOGY, 53(1), 1999, pp. 139-147
Authors:
An, G
Cazares, L
Luo, GZ
Miller, MC
Wright, GL
Veltri, RW
Citation: G. An et al., Differential expression of full-length and a truncated Her-2/neu oncogene receptor in prostate cancer assessed using relative quantitative RT-PCR, MOL UROL, 2(4), 1998, pp. 305-310